Trial Profile
MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI (Pediatric Brain Tumor Protocol)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase 0
Latest Information Update: 17 Apr 2023
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Brain cancer
- Focus Diagnostic use
- 12 Apr 2023 Status changed from recruiting to withdrawn prior to enrolment.
- 03 Jun 2022 Planned End Date changed from 1 Jun 2022 to 1 Jun 2025.
- 03 Jun 2022 Planned primary completion date changed from 1 Jun 2022 to 1 Jun 2025.